- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 13, 2025 | 43.06M sh |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $259.62K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $329.86K |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $4.47M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $1.63M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $6.37M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $6.28M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $273.27K |
| Current Assets | Q3 2025 · Mar 31, 2024 | $338.94K |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 42.24M sh |
| Shares Diluted | Q3 2025 · Dec 31, 2023 | 41.69M sh |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$440.26K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$5.57M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | −$5.86M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | −$5.9M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | −$6.03M |
| Eps Diluted | Q3 2025 · Dec 31, 2023 | −$0.01 |
| Eps Diluted restated | Q3 2025 · Dec 31, 2023 | −$0.03 |
| Eps Basic | Q3 2025 · Dec 31, 2023 | −$0.01 |
| Eps Basic restated | Q3 2025 · Dec 31, 2023 | −$0.03 |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $147.84K |
| Sga Expense | Q3 2025 · Dec 31, 2023 | $371.84K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$363.06K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$902.24K |
| Net Income | Q3 2025 · Sep 30, 2023 | −$200.98K |
| Net Income | Q3 2025 · Jun 30, 2023 | −$338.19K |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$147.84K |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$371.84K |